Forging the Fate of Cellular Therapies for Cardiovascular Disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28596173.
- Also identified by DOI 10.1161/CIRCRESAHA.117.310970 and PMC identifier 5661978.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The field of cell therapy for cardiovascular disease has progressed at an uneven rate and will likely follow the translational paths of other biologic therapies. The field will require novel public-private partnerships to guide it to its ultimate applications.
Medical subject headings
- Biological Products
- Cardiovascular Diseases
- Cell- and Tissue-Based Therapy